Cas12a-based electrochemiluminescence biosensor for target amplification-free DNA detection

Area of Science:

• Biotechnology
• Molecular Diagnostics
• Biosensor Technology

Background:

• CRISPR/Cas systems offer precise nucleic acid detection capabilities.
• Existing methods for human papilloma virus (HPV) detection can be complex and time-consuming.
• There is a need for sensitive and rapid diagnostic tools for HPV subtypes.

Purpose of the Study:

• To develop a novel Cas12a-based electrochemiluminescence (ECL) biosensor for amplification-free detection of HPV-16 DNA.
• To enhance specificity and signal amplification using Cas12a's unique recognition and trans-cleavage properties.
• To integrate L-Methionine stabilized gold nanoclusters (Met-AuNCs) as efficient ECL emitters.

Main Methods:

• Utilized the Cas12a enzyme's two-part recognition mechanism for specific HPV-16 DNA targeting.
• Employed Cas12a's trans-cleavage activity for signal amplification.
• Integrated Met-AuNCs as ECL emitters for signal transduction.
• Performed detection using electrochemiluminescence.

Main Results:

• Achieved a low detection limit of 0.48 pM for HPV-16 DNA.
• Demonstrated a rapid detection time of under 70 minutes.
• Validated the biosensor's performance using undiluted human blood samples, showing practical applicability.

Conclusions:

• The developed Cas12a-based ECL biosensor provides a sensitive and specific platform for amplification-free HPV-16 DNA detection.
• This novel approach offers a rapid and efficient diagnostic tool with potential for clinical applications.
• The findings support the advancement of CRISPR/Cas-based detection systems for broader diagnostic technologies.